MAR vs URGN · P/E 32, rev $13.72B vs rev $123.4M
Marriott International Inc (MAR) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2026-06-30 was $13.72B. Net income was $1.41B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. URGN currently screens at market cap $1.61B.
Not investment advice. Open the MAR and URGN stock pages for the full models.
Not investment advice.